Patients With Typical Laboratory Features of Autoimmune Hepatitis Rarely Need a Liver Biopsy for Diagnosis

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 1, 2011, Pages 57-63

  Björnsson, Einar ^a,b   Talwalkar, Jayant ^b   Treeprasertsuk, Sombat ^b   Neuhauser, Matthias ^b   Lindor, Keith ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b MAYO CLINIC   (United States)

Author keywords

Autoimmune Hepatitis; Diagnosis; Liver; Liver Biopsy

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER;

ADULT; BIOPSY; CLINICAL LABORATORY TECHNIQUES; FEMALE; HEPATITIS, AUTOIMMUNE; HISTOCYTOCHEMISTRY; HUMANS; LIVER; MALE; MICROSCOPY; MIDDLE AGED;

EID: 78650243282     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.07.016     Document Type: Article

References (25)

1. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 2006, 354:54-66.
2. Johnson P.J., McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993, 18:998-1005.
3. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
4. Hennes E.M., Zeniya M., Czaja A.J., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
5. Czaja A.J., Carpenter H.A. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993, 105:1824-1832.
6. Batts K.P., Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995, 19:1409-1417.
7. Czaja A.J., Freese D.K. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002, 36:479-497.
8. Bjornsson E. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacol Ther 2006, 79:521-528.
9. Czaja A.J. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998, 28:360-365.
10. Czaja A.J., Carpenter H.A. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001, 34:659-665.
11. Czaja A.J., Carpenter H.A., Santrach P.J., et al. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 2000, 31:1231-1238.
12. Adams L.A., Lindor K.D., Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2004, 99:1316-1320.
13. Manns M.P., Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006, 43:S132-S144.
14. Czaja A.J., Carpenter H.A. Optimizing diagnosis from the medical liver biopsy. Clin Gastroenterol Hepatol 2007, 5:898-907.
15. Mehendiratta V., Mitroo P., Bombonati A., et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol 2009, 7:98-103.
16. Czaja A.J., Carpenter H.A., Santrach P.J., et al. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 1993, 104:1755-1761.
17. Czaja A.J. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999, 30:394-401.
18. Feld J.J., Dinh H., Arenovich T., et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005, 42:53-62.
19. Pratt D.S., Fawaz K.A., Rabson A., et al. A novel histological lesion in glucocorticoid-responsive chronic hepatitis. Gastroenterology 1997, 113:664-668.
20. Kessler W.R., Cummings O.W., Eckert G., et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004, 2:625-631.
21. Montano-Loza A.J., Carpenter H.A., Czaja A.J. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 2007, 46:1138-1145.
22. Roberts S.K., Therneau T.M., Czaja A.J. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996, 110:848-857.
23. Schvarcz R., Glaumann H., Weiland O. Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis. J Hepatol 1993, 18:15-23.
24. Czaja A.J., Carpenter H.A. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 2004, 40:646-652.
25. Malekzadeh R., Mohamadnejad M., Nasseri-Moghaddam S., et al. Reversibility of cirrhosis in autoimmune hepatitis. Am J Med 2004, 117:125-129.